STS and EuroSCORE-2 Appropriately Assess 30-day Post-operative Mortality in the STICH Trial and a Contemporary Cohort of Patients with Left Ventricular Dysfunction Undergoing Surgical Revascularization

BACKGROUND: The Surgical Treatment for Ischemic Heart Failure (STICH) trial demonstrated a survival benefit of coronary artery bypass grafting (CABG) in patients with ischemic cardiomyopathy and left ventricular dysfunction (LVD). The Surgical Thoracic Society (STS) and the EuroSCORE-2 (ES2) are use...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Circ Heart Fail
Auteurs principaux: Bouabdallaoui, Nadia, Stevens, Susanna R., Doenst, Torsten, Petrie, Mark C., Al-Attar, Nawwar, Ali, Imtiaz S., Ambrosy, Andrew P., Barton, Anna K., Cartier, Raymond, Cherniavsky, Alexander, Demondion, Pierre, Desvigne-Nickens, Patrice, Favaloro, Robert R., Gradinac, Sinisa, Heinisch, Petra, Jain, Anil, Jasinski, Marek, Jouan, Jerome, Kalil, Renato A. K., Menicanti, Lorenzo, Michler, Robert E., Rao, Vivek, Smith, Peter K., Zembala, Marian, Velazquez, Eric J., Al-Khalidi, Hussein R., Rouleau, Jean L.
Format: Artigo
Langue:Inglês
Publié: 2018
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6309904/
https://ncbi.nlm.nih.gov/pubmed/30571194
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/CIRCHEARTFAILURE.118.005531
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires